An update on diagnosis and treatments of childhood interstitial lung diseases [0.03%]
儿童间质性肺病诊断和治疗进展
Honorata Marczak,Katarzyna Krenke,Matthias Griese et al.
Honorata Marczak et al.
Childhood interstitial lung diseases (chILDs) are rare and heterogeneous disorders associated with significant morbidity and mortality. The clinical presentation of chILD typically includes chronic or recurrent respiratory signs and symptom...
How to move towards more sustainable asthma care in Europe: an expert opinion paper [0.03%]
向更加可持续的欧洲哮喘护理迈进：专家意见书
Christer Janson,Alex Wilkinson,Hanna Hisinger-Mölkänen et al.
Christer Janson et al.
The healthcare sector is one of the primary emitters of greenhouse gases in the public sector; this viewpoint's distillation of expert opinions emphasises what more sustainable asthma care could look like and presents possible solutions to ...
Summary for clinicians: ERS guidelines on pulmonary alveolar proteinosis [0.03%]
临床医生摘要：肺泡蛋白沉积症ERS指南
Tiago Alfaro,Cormac McCarthy,Francesco Bonella et al.
Tiago Alfaro et al.
Pulmonary alveolar proteinosis (PAP) is a rare lung disease caused by accumulation of surfactant in the alveoli, leading to debilitating respiratory symptoms and impaired gas exchange. The recent European Respiratory Society guidelines prov...
Lucía Ferreiro,María E Toubes,Nuria Rodríguez-Núñez et al.
Lucía Ferreiro et al.
The term "asbestos" is used to refer to a group of silicate minerals that often break down into fibres and whose inhalation over time can cause a number of diseases, especially pleuropulmonary diseases. While the most serious complications ...
Dishant Joy Shah,Anthony Esposito,Areen Pitaktong et al.
Dishant Joy Shah et al.
B-lines and pleural line thickening on LUS are sensitive but nonspecific signs of ILD. LUS aids in early detection and monitoring, but HRCT and PFT remain the gold standards. Limitations include operator dependence and lack of standardised ...
Interstitial lung diseases [0.03%]
间质性肺疾病
Imran Sulaiman
Imran Sulaiman
This issue of Breathe focuses on interstitial lung diseases https://bit.ly/4lhll67. Copyright ©ERS 2025.
Eimear Foley,Ahmad Basirat,Ankit Yadav et al.
Eimear Foley et al.
A case demonstrating refractory cutaneous and pulmonary sarcoidosis, with classic clinical, spirometry and radiological features, despite OCS and low-dose HCQ treatment that responded clinically and functionally to the addition of a TNF inh...
Recurrent unilateral pleural effusion in a 63-year-old man: the answer lies in the mediastinum [0.03%]
63岁男性患者反复发作的单侧胸腔积液：纵隔病变是关键
Lorenzo Carriera,Guido Levi,Federico Cremonesi et al.
Lorenzo Carriera et al.
Benign vascular masses in the mediastinum, such as haemangiomas, should be considered in the differential diagnosis of unexplained pleural effusions https://bit.ly/4fOjtO1. ...
Athina Trachalaki,Anna L Lindahl,Simone Petrarulo et al.
Athina Trachalaki et al.
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease with limited treatment options. Despite the approval of pirfenidone and nintedanib that slow disease progression, IPF remains a disease with poor survival. Promising therapeutic ...
Marta Alexandra Carvalho da Silva,Rui Miguel Mouro de Santos Rolo,Maria Joana Pereira Catarata et al.
Marta Alexandra Carvalho da Silva et al.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal interstitial fibrosing disease and, despite some well-known risk factors, its cause is still unknown. Cough is experienced by most patients and is commonly chronic and ...